Research

Del.icio.us     Digg This!     Facebook     Google     Reddit     Stumble It!
title Filter     Display # 
# Article Title Author
1 03/10/2010 Press Release: "Unraveling the Mystery Behind HIV/AIDS", Singapore Agency for Science, Technology and Research webmaster
2 2/26/10 Science Daily: "Innate Mechanisms Can Control Disease Progression in HIV-Positive Patients", Barcelona, Spain research findings on dendritic cell webmaster
3 Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV (Abstract) Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, Costagliola D
4 Elite control of HIV infection: implications for vaccine design (Summary) BM Baker‌, BL Block‌, AC Rothchild‌ & BD Walker‌
5 Elite HIV controllers: myth or reality? (Abstract) Saksena NK, Rodes B, Wang B, Soriano V
6 Potential Mechanism of Long Term Control of HIV Elizabeth Reay
7 Handful of 20-year HIV survivors hold key to discovering vaccine Steve Connor, Independent Science Editor
8 Antibodies Present in Long-Term HIV Survivors Could Contribute to Vaccine Development, Study Says Kaiser Network
9 Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals webmaster
10 Potential Reason Why LTNPs Are Healthy Elizabeth Reay
11 Well- Armed Immune Cells Help LTNPs Contain HIV Loreen Willenberg
12 Recovery of Viremic Control after Superinfection with Pathogenic HIV Type 1 in a Long-Term Elite Controller of HIV Type 1 Infection Loreen Willenberg
 

Please Donate!

Please make a tax deductible donation to Zephyr LTNP Foundation, a 501(c)(3) entity via Paypal. No Paypal account required.
 

CROI 2011

  • Wednesday 9th March 2011
    This is our final bulletin from CROI 2011. We hope you have found our news coverage useful. You can find all our coverage at www.aidsmap.com/croi2011, including the news reports and bulletins.We are always looking for ways of improving and developing our resources – so if you have any comments that you would like
  • Thursday 3rd March 2011
    There is increasing evidence of the transmission of HIV strains with resistance to anti-HIV drugs in low- and middle-income countries. Research in eleven sub-Saharan African countries showed that the chances of detecting transmitted resistance increased by over a third each year that a country had been scaling up HIV treatment. A separate study involving people recently diagnosed
  • Wednesday 2nd March 2011
    A new type of anti-HIV drug that targets the first step in HIV’s entry into cells has done well in a Phase IIa study. Currently known as BMS-663068, the drug was shown to be safe and to work against the virus. HIV cell entry is a three-step process. The virus must first attach to the

Follow Us

  • Facebook Page: zephyrfoundation.org
  • Twitter: zephyrfound
  • YouTube: zephyrfoundation

Controllers in Study

 Donation Thermometer
 Donation Thermometer
 Donation Thermometer
86%

Our Goal:
2000
Currently:
1725
Updated:
December 30, 2009

Current Breakdown: 505 Elite Controllers 1009 Viremic Controllers 211 Other